Pheton holdings ltd PTHL.US 總覽分析
PTHL 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足,尚無法提供評分
PTHL 近期報酬表現
8.29%
Pheton holdings ltd
0.23%
同產業平均
0.43%
S&P500
與 PTHL 同產業的標的表現
- OPRX Optimizerx corporation價值 2 分趨勢 5 分波段 3 分籌碼 1 分股利 1 分查看更多
PTHL 公司資訊
Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company's main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company's main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian's product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.